| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.093 | 0.002 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |